Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries

被引:11
作者
Oortwijn, Wija [1 ]
van Oosterhout, Sanne [1 ]
Kapiriri, Lydia [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] McMaster Univ, Dept Hlth Aging & Soc, Main St West 1280, Hamilton, ON, Canada
关键词
Health technology assessment; Evidence-informed deliberative processes; Low-income countries; Middle-income countries; Guidance; AGENCIES; HTA;
D O I
10.1017/S0266462320000549
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives Evidence-informed deliberative processes (EDPs) were introduced to guide health technology assessment (HTA) agencies to improve their processes toward more legitimate decision making. A survey among members of the International Network of Agencies for HTA (INAHTA) showed that EDPs can also be relevant for countries that have not (yet) established such an agency. Therefore, we explored to what extent low- and middle-income countries (LMIC) applied the steps and elements stipulated in the EDP framework and their need for guidance. Methods The survey among INAHTA members was slightly adapted to address LMIC context and sent to 416 experts identified through several HTA sources. The questions focused on contextual factors and the EDP steps (installation of an appraisal committee, selecting technologies and criteria, assessment, appraisal, communication and appeal). Data collection took place between 21 May and 1 September 2019. Descriptive statistics and qualitative analyses were used to summarize the findings. Results We received sixty-six meaningful responses from experts in thirty-two LMIC. We found that contextual factors to support HTA development are overall not present or only present to some extent. Respondents indicated that guidance was needed for specific elements related to selecting technologies and criteria, assessment, appraisal, as well as communication and appeal. Conclusions EDPs have the potential to provide steps for improving HTA processes. The results of this study can serve as a baseline measurement for future monitoring and evaluation of EDP application in the responding LMIC. This could support the countries in improving their processes and enhancing legitimate decision making when using HTA.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 11 条
[1]  
[Anonymous], 2015, 2015 Global Survey on Health Technology Assessment by National Authorities Internet
[2]   Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes [J].
Baltussen, Rob ;
Jansen, Maarten Paul Maria ;
Bijlmakers, Leon ;
Grutters, Janneke ;
Kluytmans, Anouck ;
Reuzel, Rob P. ;
Tummers, Marcia ;
van der Wilt, Gert Jan .
VALUE IN HEALTH, 2017, 20 (02) :256-260
[3]   Use of Evidence-Informed Deliberative Processes - Learning by Doing [J].
Culyer, Anthony J. .
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2020, 9 (06) :263-265
[4]  
International Network of Agencies for Health Technology Assessment (INAHTA), MEMB LIST
[5]   Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective [J].
Kapiriri, Lydia ;
Baltussen, Rob ;
Oortwijn, Wija .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (01) :29-33
[6]   Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA [J].
Kristensen, Finn Borlum ;
Husereau, Don ;
Huic, Mirjana ;
Drummond, Michael ;
Berger, Marc L. ;
Bond, Kenneth ;
Augustovski, Federico ;
Booth, Andrew ;
Bridges, John F. P. ;
Grimshaw, Jeremy ;
IJzerman, Maarten J. ;
Jonsson, Egon ;
Ollendorf, Daniel A. ;
Ruether, Alric ;
Siebert, Uwe ;
Sharma, Jitendar ;
Wailoo, Allan .
VALUE IN HEALTH, 2019, 22 (01) :13-20
[7]  
Oortwijn W., 2019, EVIDENCE INFORM DELI
[8]   Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe [J].
Oortwijn, Wija ;
Jansen, Maarten ;
Baltussen, Rob .
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2020, 9 (01) :27-33
[9]  
Panda B, 2016, BMC HEALTH SERV RES, V16, P1
[10]  
World Health Organization, HTA SURV